Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longevity InTime BioTech
Wilmington, Delaware, United States
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Longevity InTime BioTech provides an AI-based hardware/software platform that continuously monitors >400 health parameters using wearables and portable biomaterial containers, aiming to predict and prevent severe diseases at preclinical stages. Current results are product/service focused, with the platform reportedly able to provide early diagnostic insights and risk scores.
- Therapeutic areas
- OncologyCardiovascularEndocrinologyOther
- Modalities
- DeviceSoftwareAI algorithmWearable devicesDiagnostics
- Industry
- Digital Health Medical Devices
02
Partnerships
No major pharmaceutical partnerships disclosed; broad collaborations with academic and technology experts
Beyond the preview
Go deeper on Longevity InTime BioTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Longevity InTime BioTech.